Medicare To Cover GLP-1 Drugs For Weight Loss Starting July 1. Here's What To Know.

CBS Bay Area

July 1 2026

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more affordable.

Called Medicare GLP-1 Bridge, the pilot program expands access to weight-loss drugs made by Eli Lilly and Novo Nordisk, including Zepbound, Foundayo and Wegovy.

"Medicare is not changing the law right now," said Juliette Cubanski, vice president and director of Medicare policy at the health care research nonprofit KFF. "What it's doing is taking advantage of a specific section of the law that gives the federal government the ability to stand up a temporary program."

Click here for the full story via CBS San Francisco Bay Area

CBS Local Digital Media personalizes the global reach of CBS-owned and operated television and radio stations with a local perspective.